Find out when events, speaker programs, and conferences sponsored by Grifols and THROMBATE III are coming to your area.

Find out when events, speaker programs, and conferences sponsored by Grifols and THROMBATE III are coming to your area.

Treatment and prevention of thromboembolism Prevention of perioperative and peripartum thromboembolism THROMBATE III prevents and treats thromboembolism in patients with hereditary AT deficiency during (...)

References:

1. THROMBATE III® (antithrombin III [human]) Prescribing Information. Grifols. 2. Heit JA, Kobbervig CW, James AH, Petterson TM, Bailey KR, Melton LJ. Ann Intern Med. 2005;143:697-706.

AT and venous thromboembolism risk

Each year, more than 250,000 patients are hospitalized for venous thromboembolism (VTE) in the United States.3 This emphasizes the importance of assessing VTE risk in patients.

Hereditary AT deficiency

Hereditary AT deficiency (HATD) presents the highest risk of thrombosis among inherited thrombophilias